Browse by Academic Unit (A-Z)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators Name | Item Type
Jump to: B | D | H | M | R | S | T | V
Number of items at this level: 13.

B

Bogaerts, J, Sydes, MR, Keat, N et al. (43 more authors) (2014) Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. European journal of cancer. ISSN 0014-2964

D

Drummond, MW, Pocock, C, Boissinot, M et al. (9 more authors) (2014) A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia. Leukemia, 28 (7). 1570 - 1572. ISSN 0887-6924

H

Hennig, IM, Naik, JD, Brown, S et al. (8 more authors) (2008) Severe sequence-specific toxicity when capecitabine is given after fluorouracil and leucovorin. Journal of Clinical Oncology, 26 (20). 3411 - 3417. ISSN 0732-183X

M

Maughan, TS, Meade, AM, Adams, RA et al. (22 more authors) (2014) A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine? British Journal of Cancer, 110 (9). 2178 - 2186. ISSN 0007-0920

Middleton, G, Brown, S, Lowe, C et al. (17 more authors) (2013) A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). European Journal of Cancer, 49 (16). 3507 - 3516. ISSN 0959-8049

Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407

R

Rosmarin, D, Palles, C, Church, D et al. (41 more authors) (2014) Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of Clinical Oncology, 32 (10). 1031 - 1039. ISSN 0732-183X

S

Seymour, MT, Brown, SR, Middleton, G et al. (18 more authors) (2013) Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. The Lancet Oncology, 14 (8). 749 - 759. ISSN 1470-2045

Smith, CG, West, H, Harris, R et al. (12 more authors) (2013) Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis. Journal of the National Cancer Institute, 105 (16). 1249 - 1253. ISSN 0027-8874

T

Taylor, S, Harley, C, Campbell, LJ et al. (6 more authors) (2010) Discussion of emotional and social impact of cancer during outpatient oncology consultations. Psycho-Oncology, 20 (3). 242 - 251 . ISSN 1099-1611

V

Varley, C.L., Stahlschmidt, J., Lee, W.C. et al. (5 more authors) (2004) Role of PPAR? and EGFR signalling in the urothelial terminal differentiation programme. Journal of Cell Science, 117 (10). pp. 2029-2036. ISSN 0021-9533

Velikova, G, Keding, A, Harley, C et al. (6 more authors) (2010) Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial. European Journal of Cancer, 46 (13). 2381 - 2388 . ISSN 1879-0852

Venderbosch, S, Nagtegaal, ID, Maughan, TS et al. (13 more authors) (2014) Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies. Clinical Cancer Research, 20. 5322 - 5330. ISSN 1078-0432

This list was generated on Thu Dec 8 03:40:17 2016 GMT.